Biddie, S.C., and John, S. (2014). Minireview: conversing with chromatin: the language of nuclear receptors. Mol. Endocrinol 28, 3–15. 10.1210/me.2013-1247.
Burris, T.P., Solt, L.A., Wang, Y., Crumbley, C., Banerjee, S., Griffett, K., Lundasen, T., Hughes, T., and Kojetin, D.J. (2013). Nuclear receptors and their selective pharmacologic modulators. Pharmacol. Rev 65, 710–778. 10.1124/pr.112.006833.
Dornas, W., Sharanek, A., and Lagente, V (2019) . Nuclear factor (erythroid derived 2)- like 2/antioxidant response element pathway in liver fibrosis. Reactive Oxygen species 7,64-67
Fernández-Gallego, N., Sánchez-Madrid, F., and Cibrian, D. (2021). Role of AHR ligands in skin homeostasis and cutaneous inflammation. Cells 10, 3176. 10.3390/cells10113176.
Frigo, D.E., Bondesson, M., and Williams, C. (2021). Nuclear receptors: from molecular mechanisms to therapeutics. Essays. Biochem 65, 847–856. 10.1042/EBC20210020.
Hebbar, P.B., and Archer, T.K. (2003). Chromatin remodeling by nuclear receptors. Chromosoma 111, 495–504. 10.1007/s00412-003-0232-x.
Heng, J.C.D., Feng, B., Han, J., Jiang, J., Kraus, P., Ng, J.H., Orlov, Y.L., Huss, M., Yang, L., Lufkin, T., et al. (2010). The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 6, 167–174. 10.1016/j.stem.2009.12.009.
Hong, S.H., Nah, H.Y., Lee, Y.J., Lee, J.W., Park, J.H., Kim, S.J., Lee, J.B., Yoon, H.S., and Kim, C.H. (2004). Expression of estrogen receptor-α and -β, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodies. Mol. Cell 18, 320–325.
Huang, J., Tabbi-Anneni, I., Gunda, V., and Wang, L. (2010). Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. Am. J. Physiol. Gastrointest. Liver Physiol 299, G1211–G1221. 10.1152/ajpgi.00322.2010.
Kaur, G., Thompson, L.A., and Dufour, J.M. (2014). Sertoli cells–immunological sentinels of spermatogenesis. Semin. Cell Dev. Biol 30, 36–44. 10.1016/j.semcdb.2014.02.011.
Kaur, G., Thompson, L.A., and Dufour, J.M. (2015). Therapeutic potential of immune privileged Sertoli cells. Anim. Reprod 12, 105–117.
Klemm, S.L., Shipony, Z., and Greenleaf, W.J. (2019). Chromatin accessibility and the regulatory epigenome. Nat. Rev. Genet 20, 207–220. 10.1038/s41576-018-0089-8.
Lee, D.Y., Hayes, J.J., Pruss, D., and Wolffe, A.P. (1993). A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72, 73–84. 10.1016/0092-8674(93)90051-Q.
Li, J., Buchner, J., and Li, J. (2013). Structure, function and regulation of the hsp90 machinery. Biomed. J 36, 106–117. 10.4103/2319-4170.113230.
Liang, J., Wang, N., He, J., Du, J., Guo, Y., Li, L., Wu, W., Yao, C., Li, Z., and Kee, K. (2019). Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4. ELife 8, e48767. 10.7554/eLife.48767.
Luca, G., Arato, I., Sorci, G., Cameron, D.F., Hansen, B.C., Baroni, T., Donato, R., White, D.G.J., and Calafiore, R. (2018). Sertoli cells for cell transplantation: pre-clinical studies and future perspectives. Andrology 6, 385–395. 10.1111/andr.12484.
Luger, K., Mäder, A.W., Richmond, R.K., Sargent, D.F., and Richmond, T.J. (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251–260. 10.1038/38444.
McEwan, I.J., and Kumar, R. (2015). Nuclear Receptors: From Structure to the Clinic (Springer International Publishing).
Mital, P., Kaur, G., and Dufour, J.M. (2010). Immunoprotective sertoli cells: making allogeneic and xenogeneic transplantation feasible. Reprod 139, 495–504. 10.1530/REP-09-0384.
Akhileshwar Namani, Yulong Li, Xiu JunWang, Xiuwen Tang (2014). Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer. Biochimica et Biophysica Acta 1843, 1875–1885
Nakatsuji, T., and Gallo, R. L. (2019). The role of the skin microbiome in atopic dermatitis. Ann. Allergy Asthma Immunol 122, 263-269.
Nikitin, A., Egorov, S., Daraselia, N., and Mazo, I. (2003). Pathway studio--the analysis and navigation of molecular networks. Bioinformatics 19, 2155–2157. 10.1093/bioinformatics/btg290.
Pike, J.W., and Meyer, M.B. (2010). The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Endocrinol. Metab. Clin. North. Am 39, 255–269. 10.1016/j.ecl.2010.02.007.
Raghavan, P.R. (2015). Metadichol liquid and gel nanoparticle formulations. US patent 9,006,292 B2.
Raghavan, P.R. (2017). Metadichol ®. A novel inverse agonist of Aryl Hydrocarbon Receptor (AHR) and NRF2 inhibitor. J. Cancer. Sci. Ther 9, 661–668. 10.4172/1948-5956.1000489.
Raghavan, P.R. (2017-1). Metadichol, a novel ROR gamma inverse agonist and its applications in psoriasis. J. Clin. Exp. Dermatol. Res 8, 433. 10.4172/2155-9554.1000433.
Raghavan, P.R. (2019). Metadichol® A novel inverse agonist of thyroid receptor and its applications in thyroid diseases. Biol. Med 11, 2. 10.4172/0974-8369.1000458.
Raghavan, P.R. (2022). Metadichol, a natural ligand for expression of Yamanaka reprogramming factors in somatic and primary cancer cell lines. Preprint at Research Square, 10.21203/rs.3.rs-1727437/v3.
Rotgers, E., Jørgensen, A., and Yao, H.H.C. (2018). At the crossroads of fate-somatic cell lineage specification in the fetal gonad. Endocr. Rev 39, 739–759. 10.1210/er.2018-00010.
Rothhammer, V., & Quintana, F.J. (2019). The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat. Rev. Immunol 19, 184-197.
Roztocil, E., Hammond, C.L., Gonzalez, M.O., Feldon, S.E., and Woeller, C.F. (2020). The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts. Sci. Rep 10, 1-16.
Sivachenko, A.Y., Yuryev, A., Daraselia, N., and Mazo, I. (2007). Molecular networks in microarray analysis. J. Bioinform. Comput. Biol 5, 429–456. 10.1142/S0219720007002795.
Sladek, F.M. (2011). What are nuclear receptor ligands? Mol. Cell. Endocrinol 334, 3–13. 10.1016/j.mce.2010.06.018.
Xie, C.Q., Jeong, Y., Fu, M., Bookout, A.L., Garcia-Barrio, M.T., Sun, T., Kim, B.H., Xie, Y., Root, S., Zhang, J., et al. (2009). Expression profiling of nuclear receptors in human and mouse embryonic stem cells. Mol. Endocrinol 23, 724–773. 10.1210/me.2008-0465
Xue,D., Zhou,X., & Qiu, J (2020). Emerging role of NRF2 in ROS-mediated tumor chemoresistance. Biomed Pharmaoother 131, 110676
Yagashita, Y., Gatbonto Schwager, T.N. McCallum, M.L., & Kensler, T. (2020). Current landscape of NRF2 biomarkers in clinical trials. Antioxidants 9, 716.
Yang, H.M., Do, H.J., Kim, D.K., Park, J.K., Chang, W.K., Chung, H.M., Choi, S.Y., and Kim, J.H. (2007). Transcriptional regulation of human Oct4 by steroidogenic factor 1. J. Cell. Biochem 101, 1198–1209. 10.1002/jcb.21244.
Zaret, K.S., and Yamamoto, K.R. (1984). Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element. Cell 38, 29–38. 10.1016/0092-8674(84)90523-3.